Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion type Assertion NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_head.
- NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion description "[Our findings illuminate the mechanistic details of KRAS-mediated drug resistance and provide a preclinical rationale to improve the management of lung tumors harboring KRAS mutations with NRF2 pathway inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_provenance.
- NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion evidence source_evidence_literature NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_provenance.
- NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion SIO_000772 25339352 NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_provenance.
- NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion wasDerivedFrom befree-2016 NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_provenance.
- NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_assertion wasGeneratedBy ECO_0000203 NP1231935.RAuvMt7bQKLAh44M_Xrd2pPak_b8H0mmXWyV-osA0neBA130_provenance.